These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 28767652)
1. Comparative studies of three cholesteryl ester transfer proteins and their interactions with known inhibitors. Wang Z; Niimi M; Ding Q; Liu Z; Wang L; Zhang J; Xu J; Fan J PLoS One; 2017; 12(8):e0180772. PubMed ID: 28767652 [TBL] [Abstract][Full Text] [Related]
2. Anacetrapib and dalcetrapib differentially alters HDL metabolism and macrophage-to-feces reverse cholesterol transport at similar levels of CETP inhibition in hamsters. Briand F; Thieblemont Q; Muzotte E; Burr N; Urbain I; Sulpice T; Johns DG Eur J Pharmacol; 2014 Oct; 740():135-43. PubMed ID: 25008069 [TBL] [Abstract][Full Text] [Related]
3. Cholesteryl ester transfer protein: An enigmatic pharmacology - Antagonists and agonists. Yamashita S; Ruscica M; Macchi C; Corsini A; Matsuzawa Y; Sirtori CR Atherosclerosis; 2018 Nov; 278():286-298. PubMed ID: 30347344 [TBL] [Abstract][Full Text] [Related]
4. Mechanism of Inhibition of Cholesteryl Ester Transfer Protein by Small Molecule Inhibitors. Chirasani VR; Sankar R; Senapati S J Phys Chem B; 2016 Aug; 120(33):8254-63. PubMed ID: 27111423 [TBL] [Abstract][Full Text] [Related]
5. The effect of cholesteryl ester transfer protein overexpression and inhibition on reverse cholesterol transport. Tchoua U; D'Souza W; Mukhamedova N; Blum D; Niesor E; Mizrahi J; Maugeais C; Sviridov D Cardiovasc Res; 2008 Mar; 77(4):732-9. PubMed ID: 18056760 [TBL] [Abstract][Full Text] [Related]
6. Steering the Lipid Transfer To Unravel the Mechanism of Cholesteryl Ester Transfer Protein Inhibition. Dixit SM; Ahsan M; Senapati S Biochemistry; 2019 Sep; 58(36):3789-3801. PubMed ID: 31418269 [TBL] [Abstract][Full Text] [Related]
7. How anacetrapib inhibits the activity of the cholesteryl ester transfer protein? Perspective through atomistic simulations. Äijänen T; Koivuniemi A; Javanainen M; Rissanen S; Rog T; Vattulainen I PLoS Comput Biol; 2014 Nov; 10(11):e1003987. PubMed ID: 25412509 [TBL] [Abstract][Full Text] [Related]
8. The controversy over the use of cholesteryl ester transfer protein inhibitors: is there some light at the end of the tunnel? Quintão EC Eur J Clin Invest; 2016 Jun; 46(6):581-9. PubMed ID: 26992444 [TBL] [Abstract][Full Text] [Related]
9. Anacetrapib, but not evacetrapib, impairs endothelial function in CETP-transgenic mice in spite of marked HDL-C increase. Simic B; Mocharla P; Crucet M; Osto E; Kratzer A; Stivala S; Kühnast S; Speer T; Doycheva P; Princen HM; van der Hoorn JW; Jukema JW; Giral H; Tailleux A; Landmesser U; Staels B; Lüscher TF Atherosclerosis; 2017 Feb; 257():186-194. PubMed ID: 28152406 [TBL] [Abstract][Full Text] [Related]
10. Antisense oligonucleotide inhibition of cholesteryl ester transfer protein enhances RCT in hyperlipidemic, CETP transgenic, LDLr-/- mice. Bell TA; Graham MJ; Lee RG; Mullick AE; Fu W; Norris D; Crooke RM J Lipid Res; 2013 Oct; 54(10):2647-57. PubMed ID: 23801661 [TBL] [Abstract][Full Text] [Related]
11. Cholesteryl ester transfer protein (CETP) inhibitors. Hunt JA; Lu Z Curr Top Med Chem; 2009; 9(5):419-27. PubMed ID: 19519458 [TBL] [Abstract][Full Text] [Related]
13. The novel compound NO-1886 elevates plasma high-density lipoprotein cholesterol levels in hamsters and rabbits by increasing lipoprotein lipase without any effect on cholesteryl ester transfer protein activity. Tsutsumi K; Inoue Y; Hagi A; Murase T Metabolism; 1997 Mar; 46(3):257-60. PubMed ID: 9054466 [TBL] [Abstract][Full Text] [Related]
14. Cholesteryl ester transfer proteins from different species do not have equivalent activities. Morton RE; Izem L J Lipid Res; 2014 Feb; 55(2):258-65. PubMed ID: 24293641 [TBL] [Abstract][Full Text] [Related]
15. The lipid substrate preference of CETP controls the biochemical properties of HDL in fat/cholesterol-fed hamsters. Morton RE; Mihna D; Liu Y J Lipid Res; 2021; 62():100027. PubMed ID: 33515552 [TBL] [Abstract][Full Text] [Related]
16. Increasing HDL levels by inhibiting cholesteryl ester transfer protein activity in rabbits with hindlimb ischemia is associated with increased angiogenesis. Wu BJ; Shrestha S; Ong KL; Johns D; Dunn LL; Hou L; Barter PJ; Rye KA Int J Cardiol; 2015 Nov; 199():204-12. PubMed ID: 26204569 [TBL] [Abstract][Full Text] [Related]
17. Modulating cholesteryl ester transfer protein activity maintains efficient pre-β-HDL formation and increases reverse cholesterol transport. Niesor EJ; Magg C; Ogawa N; Okamoto H; von der Mark E; Matile H; Schmid G; Clerc RG; Chaput E; Blum-Kaelin D; Huber W; Thoma R; Pflieger P; Kakutani M; Takahashi D; Dernick G; Maugeais C J Lipid Res; 2010 Dec; 51(12):3443-54. PubMed ID: 20861162 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of Cholesteryl Ester Transfer Protein Preserves High-Density Lipoprotein Cholesterol and Improves Survival in Sepsis. Trinder M; Wang Y; Madsen CM; Ponomarev T; Bohunek L; Daisely BA; Julia Kong H; Blauw LL; Nordestgaard BG; Tybjærg-Hansen A; Wurfel MM; Russell JA; Walley KR; Rensen PCN; Boyd JH; Brunham LR Circulation; 2021 Mar; 143(9):921-934. PubMed ID: 33228395 [TBL] [Abstract][Full Text] [Related]
19. Cholesteryl ester transfer protein (CETP) deficiency and CETP inhibitors. Mabuchi H; Nohara A; Inazu A Mol Cells; 2014 Nov; 37(11):777-84. PubMed ID: 25410905 [TBL] [Abstract][Full Text] [Related]
20. The lipid transfer properties of CETP define the concentration and composition of plasma lipoproteins. Morton RE; Liu Y J Lipid Res; 2020 Aug; 61(8):1168-1179. PubMed ID: 32591337 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]